In this study, we employ a novel metastatic breast cancer tumor model, TUBO-P2J, to discover mechanisms promoting metastatic progression in breast cancer, and susceptibility to chemotherapeutics and anti-neu therapy. Here, ERBB2 is linked to neoplasm.